Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Effects of squalene on the immune responses in mice(II): Cellular and non-specific immune response and antitumor activity of squalene


Effects of squalene on cellular and non-specific immune responses and antitumor activity in mice were investigated. Cellular and non-specific immunological assay parameters adopted in the present study were delayed-type hypersensitivity reaction and rosette forming cells (RFC) for cellular immunity, activities of natural killer (NK) cells and phagocyte for non-specific immunity. Squalene resulted in marked increases of cellular and non-specific immune functions and enhancement of host resistance to tumor challenge in dose-dependent manner.

This is a preview of subscription content, log in to check access.

Literature Cited

  1. 1.

    Lemperle, G.: Immunization againstsarcoma 180 potentiated by RES stimulation.J. Reticuloendothel. Soc. 3, 385 (1966).

  2. 2.

    Ribi, E., McLaughlin, C. A., Cantrell, J. L., Brehmer, W., Azuma, I., Yamamura, Y., Stain, S. M., Hwang, K.M. and Toubiana, R.: Immunotherapy for tumors with microbial constituents or their synthetic analogues-review. In: The University of Texas System Cancer Center, M. D.Anderson Anderson Hospital and TumorInstitute (ed), “Immunotherapy of Human Cancer”, Raven Press, New York, NY 1978, p. 131.

  3. 3.

    Yamaguchi, T., Nakagawa, M., Hidaka, K., Yoshida, T., Sasaki, T., Akiyama, S. and Kuwano, M.: Potentiation by squalene of antitumor of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitrosourea in a murine tumor system.JPN. J. Cancer Res. (Gann) 76, 1021 (1985).

  4. 4.

    Yarkoni, E., Meltzer, M. S. and Rapp, H. J.; Tumor regression after intralesional injection of emulsified trehalose-6,6°-dimycolate (cord factor): efficacy increases with oil concentration.Int. J. Cancer 19, 818 (1977).

  5. 5.

    Ikekawa, T., Umeji, M., Manabe, T., Yonoma, S., Irinida, K., Mizunuma, H. and Ikekawa, N.: Studies on antitumor activity of squalene and its related compounds.Yakugaku Zasshi 106, 578 (1986).

  6. 6.

    Yamawaki, M., Azuma, I., Saiki, I., Uemiya, M., Aoki, O., Ennyu, K. and Yamamura, Y.: Antitumor activity of squalene-treated cell wall skeleton ofNocardia rubra in mice.Gann. 69, 619 (1978).

  7. 7.

    Hirai, O., Fujitsu, T., Satoh, H., Mori, J. and Kikuchi, H.: Influence of squalene on the antitumor action of cell wall skeleton fromNocardia rubra.Oyo Yakuri Pharmacometrics 31, 649 (1986).

  8. 8.

    Ohkuma, T., Otagiri, K., Tanaka, S. and Ikekawa, J.: Intensification of host's immunity by squalene insarcoma 180 bearing ICR mice.J. Pharm. Dyn. 6, 148 (1983).

  9. 9.

    Kohashi, O., Pearson, C. M., Beck, F. J. W. and Alexander, M.:Infec. Immunol. 17, 244 (1977).

  10. 10.

    Ahn, Y. K. and Kim, J. H.: Effects of squalene on the immune responses in mice (I).Arch. Pharm. Res. 14, 378 (1991).

  11. 11.

    Reed, N. D., Crowle, P. K. and Ha, T.: Use of mast cell deficient mice to study host parasite relationships in immuno-deficient animals.B. Ssordeted. Karger Baselip 184 (1984).

  12. 12.

    Lake, J. P. and Reed, N. D.: Characterization of antigen specific immunogic paralysis induce by a single low dose of polyvinylpyrrolidone.J. Reticuloendothel. Soc. 20, 307 (1976).

  13. 13.

    Mishell, B. B., Shiigi, S. M., Henry, C., Chan, E. L., North, J., Gallily, R., Slomich, M., Miller, K., Marbrook, J., Parks, D. and Good, A. H.: Preparation of mouse cell suspensions. In: Mishell, B. B. and Shiigi, S. M. (Eds.) “Selected Methods in Cellular Immunology”, Freeman. San Francisco, CA p. 3, (1980).

  14. 14.

    Titus, R. G. and Chiller, J. M.: A simple and effective methods to assess murine delayed type hypersensitivity to proteins.J. Immunol. Methods 45, 65 (1981).

  15. 15.

    Henningsen, G. M., Koller, L. D., Exon, J. H., Talcott, P. A. and Osborne, C. A.: A sensitive delayed type hypersensitivity model in the rats for assessingin vivo cell mediated immunity.J. Immunol. Methods 70, 153 (1984).

  16. 16.

    Garvey, J. S., Cremer, N. E. and Sussclorf, D. H.: “Methods in Immunology”, 3rd, Benjamin 1980. p. 449.

  17. 17.

    Elliott, B. E. and Haskill, J. S.: Characteristics of thymus-derived bone marrow-derived rosette forming lymphocytes.Eur. J. Immunol. 3, 68 (1973).

  18. 18.

    Kiesseling, R., Kleing, E. and Wigzell, H.: “Nature Killer Cells in the Mouse”,Eur. J. Immunol. 5, 112 (1975).

  19. 19.

    Biozzi, G., Benacerraf, B., Stiffel, C. and Halpern, B. N.: Quantitative study of the granulopectic activity of the reticuloendothelial system.Brit. J. Exper. Path. 34, 141 (1954).

  20. 20.

    NIH publication No.84-2635: “In Vivo Cancer Models”, 1976–1982, National Institute of Health, Bethesda, Maryland 1984, p. 15.

  21. 21.

    Snedecorm, G.W. and Cochrane, W. G.: “Statistical methods”, 6th ed. Iowa State University Press, Iowa. 1967. p. 1.

  22. 22.

    Diem, B. J. and Lentner, C.: “Documenta Geigy Scientific Tables”, Geigy, New York, NY p. 158 (1975).

  23. 23.

    Henson, P. M.: Mechanisms of tissue injury produced by immunologic reactions. In “Immunology”, Bellanti, Saunders, Co, Philadelphia (1985),p.218.

  24. 24.

    Sugimoto, M., Kojima, A. M., Yaginuma, K. and Gashira, Y. E.: Cell mediated and humoral immunity in mice.JPN. J. Med. Sci. Biol. 28, 23 (1975).

  25. 25.

    Back, J. E. and Dardenne, M.: Antigen recognition by T-lymphocytes.Cell. Immunol. 3, 1 (1972).

  26. 26.

    Tilvis, R. S. and Miettinen, T. A.: Dietary squalene increases tissue sterols and fecal bile acids in the rat.Lipids 18, 32 (1983).

  27. 27.

    Offner, H. and Clausen, T.: Inhibition of lymphocyte response to stimulants induced by unsaturated fatty acid and prostaglandins.Lancet 17, 400 (1974).

  28. 28.

    Brock, N., Gross, R., Hohorst, H. J., Klein, H. O. and Schneider, B.: Activation of cyclophosphamide in man and animals.Cancer 27, 1520 (1968).

  29. 29.

    Mertin, H., Cohen, M. D., Paul, P. and Carbone, M. D.: Enhancement of the antitumor effects of 1,3-bis (2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A.J. Natl. Cancer Institute 48, 921 (1972).

  30. 30.

    Wheeler, A. G., Dansby, D., Hawkins, H. C., Payne, H. G. and Weikel, J. H.: A toxicologic and hematologic evaluation of cyclophosphamide in experimental animals.Toxicol. Appl. Pharmacol. 4, 324 (1962).

  31. 31.

    Livingston, R. B. and Carter, S. K.: “Single Agent in Cancer Chemotherapy”, IF I/Plenum. New York, NY 1970, p.25.

  32. 32.

    Hersh, E. M.: Immunosuppressive agents. In: (Sartoreli, A. C. and Johns O. G. Eds). Handbook of experimental pharmacology. Part. I. Antineoplastic and immunosuppressive agents,Springer-Verlag. Berlin 38, 577 (1974).

  33. 33.

    Ahn, Y. K., Kim, J. H., Lee, S. K. and Kim, H. S.: The effect of eicosapentaenoic acid on the immune response in mice.Yakkak Hoeji 33, 20 (1989).

  34. 34.

    Oh, Y. J.: Effect of evening primrose oil (EPO) on the immune response in mice.Thesis Collection, Graduate School of Won Kwang University (1988).

  35. 35.

    Yamaguchi, T., Ikezaki, K., Kishiye, T., Tahara, Y., Koyama, H., Takahashi, T., Fukawa, H., Komiyama, S., Akiyama, S. and Kuwano, M.: Potentiation of anticancer agents by new synthetic isoprenoides. Inhibition of the growth of transplanted tumor.J. Natl. Cancer Inst. 73, 903 (1984).

  36. 36.

    Ikezaki, K., Yamaguchi, T., Ueda, H., Miyazaki, C., Kishiye, T., Tahara, Y., Koyama, H., Takahashi, T., Fukawa, H., Komiyama, S. and Kuwano, M.: Potentiation of anticancr agents by new synthetic isoprenoids. I. Inhibition of the growth of cultured mammalian cells.J. Natl. Cancer Institute 73, 895 (1984).

Download references

Author information

Correspondence to Young Keun Ahn.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ahn, Y.K., Kim, J.H. Effects of squalene on the immune responses in mice(II): Cellular and non-specific immune response and antitumor activity of squalene. Arch. Pharm. Res. 15, 20–29 (1992).

Download citation


  • Squalene
  • delayed-type hypersensitivity reaction
  • rosette forming cell
  • natural killer cell activity
  • phagocytic activity
  • host resistance to tumor challenge